Aptevo Therapeutics Inc. - Common Stock (APVO)

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.

Aptevo stock is trading lower after the company announced a 1-for-37 reverse stock split.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

The company said that net proceeds from the offering will be used for the continued clinical development of product candidates, as working capital, and for other general corporate purposes.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Aptevo Therapeutics reports strong remission rates in AML patients using mipletamig plus ven/aza, with Cohort 2 enrollment nearing completion.